Abstract
Somatic gene repair of disease-causing chromosomal mutations is a novel approach for gene therapy. This method would ensure that the corrected gene is regulated by its endogenous promoter and expressed at physiological levels in the appropriate cell types. A reporter mouse, Gtrosa26tm1Col, was generated by targeting a mutated LacZ gene to the Rosa26 locus in mouse embryonic stem (ES) cells. The LacZ gene contains a G to A point mutation, resulting in a Glu to Lys amino-acid substitution at position 461, which abrogates enzymatic activity. The gene is expressed in ES cells, primary embryonic fibroblasts, and in all tissues examined in the adult mouse, including the lung, liver, kidney, spleen, heart, brain and smooth muscle. This transgenic mouse will allow testing of gene repair strategies in vivo and identification of which cell types can be successfully targeted by chromosomal gene repair. Although low levels of gene repair were achieved in the ES cells used to generate the Gtrosa26tm1Col mouse, preliminary attempts at gene repair in vivo were unsuccessful, thus highlighting the difficulties that will have to be overcome to get this approach to work.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexeev V, Yoon K . Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA–DNA oligonucleotide. Nat Biotechnol 1998; 16: 1343–1346.
Xiang Y et al. Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide. J Mol Med 1997; 75: 829–835.
Igoucheva O, Peritz AE, Levy D, Yoon K . A sequence-specific gene correction by an RNA–DNA oligonucleotide in mammalian cells characterized by transfection and nuclear extract using a lacZ shuttle system. Gene Therapy 1999; 6: 1960–1971.
Igoucheva O, Alexeev V, Yoon K . Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Therapy 2001; 8: 391–399.
Nickerson HD, Colledge WH . A comparison of gene repair strategies in cell culture using a lacZ reporter system. Gene Therapy 2003; 10: 1584–1591.
Lu IL et al. Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies. Gene Therapy 2003; 10: 1910–1916.
Kren BT, Bandyopadhyay P, Steer CJ . In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides (see comments). Nat Med 1998; 4: 285–290.
Kren BT et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler–najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci USA 1999; 96: 10349–10354.
Alexeev V et al. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA–DNA oligonucleotide (see comments). Nat Biotechnol 2000; 18: 43–47.
Bartlett RJ et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA:DNA oligonucleotide. Nat Biotechnol 2000; 18: 615–622.
Goncz KK et al. Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Therapy 2001; 8: 961–965.
Kapsa R et al. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther 2001; 12: 629–642.
Tagalakis AD et al. Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J Biol Chem 2001; 276: 13226–13230.
Zambrowicz BP et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 1997; 94: 3789–3794.
Friedrich G, Soriano P . Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 1991; 5: 1513–1523.
Soriano P . Generalized lacZ expression with the ROSA26 Cre reporter strain (letter). Nat Genet 1999; 21: 70–71.
Mao X, Fujiwara Y, Orkin SH . Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci USA 1999; 96: 5037–5042.
Awatramani R, Soriano P, Mai JJ, Dymecki S . An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nat Genet 2001; 29: 257–259.
Cupples CG, Cabrera M, Cruz C, Miller JH . A set of lacZ mutations in Escherichia coli that allow rapid detection of specific frameshift mutations. Genetics 1990; 125: 275–280.
Igoucheva O, Yoon K . Targeted single-base correction by RNA–DNA oligonucleotides. Hum Gene Ther 2000; 11: 2307–2312.
Pierce EA et al. Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Therapy 2003; 10: 24–33.
Cervantes RB et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002; 99: 3586–3590.
Dowty ME et al. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci USA 1995; 92: 4572–4576.
Hagstrom JE et al. Nuclear import of DNA in digitonin-permeabilized cells. J Cell Sci 1997; 110 (Part 18): 2323–2331.
Kohler SW et al. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen 1991; 18: 316–321.
Gossen JA et al. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA 1989; 86: 7971–7975.
Monroe JJ et al. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. Mutat Res 1998; 421: 121–136.
McMahon JM et al. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Therapy 1998; 5: 1283–1290.
Thorpe P, Stevenson BJ, Porteous DJ . Optimising gene repair strategies in cell culture. Gene Therapy 2002; 9: 700–702.
Alexeev V, Igoucheva O, Yoon K . Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Therapy 2002; 9: 1667–1675.
Gonzaez-Guerrico AM et al. Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J Biol Chem 2002; 277: 17239–17247.
Goncz KK et al. Application of SFHR to gene therapy of monogenic disorders. Gene Therapy 2002; 9: 691–694.
Scott ES, Wiseman JW, Evans MJ, Colledge WH . Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med 2001; 3: 125–134.
Colosimo A et al. Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Mol Ther 2001; 3: 178–185.
Wiseman JW, Goddard CA, Colledge WH . Steroid hormone enhancement of gene delivery to a human airway epithelial cell line in vitro and mouse airways in vivo. Gene Therapy 2001; 8: 1562–1571.
Pitard B et al. A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles. Hum Gene Ther 2002; 13: 1767–1775.
Acknowledgements
HDN was funded by an MRC studentship, WHC is funded by the Ford Physiology Fund. We would like to thank Dr Bruno Pitard, INSERM, Nantes, France for supplying us with the PE6400 reagent.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nickerson, H., Colledge, W. A LacZ-based transgenic mouse for detection of somatic gene repair events in vivo. Gene Ther 11, 1351–1357 (2004). https://doi.org/10.1038/sj.gt.3302311
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302311
Keywords
This article is cited by
-
Gene targeting in vivo by adeno-associated virus vectors
Nature Biotechnology (2006)
-
A trial of somatic gene targeting in vivo with an adenovirus vector
Genetic Vaccines and Therapy (2005)
-
Implications of cell cycle progression on functional sequence correction by short single-stranded DNA oligonucleotides
Gene Therapy (2005)
-
Gene therapy progress and prospects: targeted gene repair
Gene Therapy (2005)